Key Takeaways:
- Morgan Stanley, Marex Group and three other firms file SpaceX structured notes
- Notes offer up to 50% downside protection while capping future gains
- Product wave signals institutional expectation of further post-IPO selling
Key Takeaways:

At least five financial institutions are filing structured notes tied to SpaceX stock that cap investor gains while offering up to 50% downside protection, betting the post-IPO selloff has further to run, according to regulatory filings.
Morgan Stanley, Marex Group Ltd. and at least three other firms have submitted filings to launch structured products linked to SpaceX shares, the documents show. The notes limit investor losses — some offering protection on as much as half of any decline — while capping appreciation over periods spanning months to years.
The product structure reflects deepening concern among institutional investors that SpaceX shares face additional selling pressure after the initial public offering. SpaceX, Elon Musk's rocket and satellite company, has seen its stock decline sharply since listing, eroding early gains and prompting Wall Street to engineer hedges for risk-averse clients.
The filings represent a rapid response from the structured notes market, which typically takes weeks to months to develop products tied to newly public companies. The speed of the rollout suggests pre-existing institutional demand for SpaceX exposure with defined risk parameters.
For investors, the trade-off is straightforward: surrender any upside beyond a preset cap in exchange for a floor that limits losses. The capped return structure means buyers are effectively betting that SpaceX shares will not rally sharply in the near term, even as they seek protection against further declines.
The wave of filings also raises questions about the depth of institutional conviction in SpaceX's long-term valuation. While the company commands a multibillion-dollar market capitalization driven by its Starlink satellite network and Starship rocket program, the structured note terms imply that Wall Street sees material downside risk in the months ahead.
Regulatory approval of the products could open the door for broader retail access to SpaceX equity through broker-sold structured notes, expanding the investor base beyond the institutional and accredited investors who participated in the IPO. That would mark a significant shift in how SpaceX shares trade, potentially increasing liquidity but also exposing the stock to broader market sentiment swings.
This article is for informational purposes only and does not constitute investment advice.